Imagion Biosystems Limited (ASX:IBX)

Australia · Delayed Price · Currency is AUD

0.0160

-0.0020 (-11.11%)

Jun 5, 2026, 4:10 PM AEST

Revenue by Segment

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Research & Development	73.03K	2.67M	4.97M	3.07M	2.86M
Research & Development Growth	-97.26%	-46.38%	61.87%	7.54%	5.88%
Total	73.03K	2.67M	4.97M	3.07M	2.86M
Total Growth	-97.26%	-46.38%	61.87%	7.54%	5.88%

Revenue by Geography

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States of America	-	1.21M	1.37M	520.21K	232.93K
United States of America Growth	-	-11.89%	163.67%	123.33%	-
Australia	73.03K	1.46M	3.60M	49.75K	10.48K
Australia Growth	-94.99%	-59.53%	7133.84%	374.98%	-99.61%
Total	73.03K	2.67M	4.97M	569.96K	243.41K
Total Growth	-97.26%	-46.38%	772.13%	134.16%	-90.97%

Source: S&P Global Market Intelligence.